PATENT CLAIM ANALYSIS

Application Number: 15985761
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["435", "069100"]

Abstract:
A system, including methods and compositions, for treatment of ischemia.

Claim (Index 40):
The composition of  claim 26 , wherein the ASIC1a inhibitor is a derivative of PcTx1 and wherein the derivative of PcTx1 differs from PcTx by at least one deletion, substitution, and/or addition of one or more amino acids.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.08333
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15167702', '14660581', '15638655', '11724859', '13284166']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.639121282456226
- 35 USC 102 Novelty (BERT): 0.5355598466082756
- Combined Prediction Score: 0.628765138871431
- Mean Citation Score: 346.39145599999995
- Max Citation Score: 354.43805
- Similarity Product: 210.1770084062337

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test